Hereby, the CD8+ T cells (cytotoxic T cells) detect abnormal antigens produced by cancer cells and target these neoantigen-presenters for destruction as well as secreting factors which limit more extensive tumor establishment (e.g., inhibiting angiogenesis by secreting interferon gamma into the TME) [140, 155, 156]. The gene discussed is CD8A; the disease is neoplasm.